ImmuCell
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ImmuCell's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6% to $17,471,669. Profit margin reached -33%. Total operating expenses were $9,617,362.

Profit Margin

ImmuCell Corporation (NASDAQ:ICCC): Profit margin
2014 7.59M -167.15K -2.2%
2015 10.22M 1.21M 11.86%
2016 9.54M 508.44K 5.33%
2017 10.43M -168K -1.61%
2018 10.98M -2.32M -21.14%
2019 13.72M -1.29M -9.44%
2020 15.34M -1.02M -6.66%
2021 19.24M -78K -0.41%
2022 18.56M -2.49M -13.43%
2023 17.47M -5.77M -33.05%

ICCC Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
17.47M18.56M19.24M15.34M13.72M10.98M10.43M9.54M10.22M7.59M
Cost of revenue
13.07M10.91M10.58M8.47M6.98M5.79M5.21M4.12M3.97M3.14M
Gross profit
4.39M7.64M8.65M6.86M6.74M5.19M5.22M5.42M6.25M4.44M
Operating exp.
Research and development
4.39M4.49M4.16M4.35M3.68M3.51M2.04M1.24M1.23M2.17M
Selling and marketing
3.08M5.45M4.23M3.88M4.00M3.82M3.41M1.83M1.60M1.31M
Total operating expenses
9.61M9.94M8.39M8.24M7.69M7.34M5.46M4.53M4.12M4.65M
Operating income
-5.74M-2.29M-2.20M-1.38M-954K-1.44M-243K890.20K2.12M-206.39K
Other income (expenses), net
-21.89K-187K2.13M348.1K-314K287K-195.63K-24.84K-58.77K-49.05K
Income before tax
-5.76M-2.48M-69K-1.03M-1.26M-1.86M-438K758.32K2.06M-255.45K
Income tax expense
4.62K8K9K-10K28K462K-270K249.87K850.30K-88.29K
Net income
-5.77M-2.49M-78K-1.02M-1.29M-2.32M-168K508.44K1.21M-167.15K
Earnings per share
Basic EPS
-0.75-0.32-0.01-0.14-0.19-0.42-0.030.120.4-0.05
Diluted EPS
-0.75-0.32-0.01-0.14-0.19-0.42-0.030.120.38-0.05
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source